SeqOnce BioSciences Inc., a biotech startup based in Pasadena, has raised $1 million in its latest financing round, according to securities filings.
The life sciences firm, one of nearly two dozen to share workspace at Pasadena Bio Sciences Collaborative, raised more than $1 million from 12 investors, according to a filing posted April 26 with the U.S. Securities and Exchange Commission.
SeqOnce BioSciences develops rapid DNA library preparation kits from technology licensed from USC to streamline next generation sequencing for academic and clinical markets.
It had raised $455,000 in three previous seed rounds since 2014, according to Crunchbase. Michael Giardello, listed as a partner for Mount Wilson Ventures in Pasadena, was named as a company director on its latest securities filing.
Health business reporter Dana Bartholomew can be reached at firstname.lastname@example.org. Follow him on Twitter @_DanaBart.